Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-6261
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarthels, Fabian-
dc.contributor.authorMarincola, Gabriella-
dc.contributor.authorMarciniak, Tessa-
dc.contributor.authorKonhäuser, Matthias-
dc.contributor.authorHammerschmidt, Stefan-
dc.contributor.authorBierlmeier, Jan-
dc.contributor.authorDistler, Ute-
dc.contributor.authorWich, Peter R.-
dc.contributor.authorTenzer, Stefan-
dc.contributor.authorSchwarzer, Dirk-
dc.contributor.authorZiebuhr, Wilma-
dc.contributor.authorSchirmeister, Tanja-
dc.date.accessioned2021-08-13T07:36:00Z-
dc.date.available2021-08-13T07:36:00Z-
dc.date.issued2020-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/6271-
dc.description.abstractStaphylococcus aureus is one of the most frequent causes of nosocomial and community-acquired infections, with drug-resistant strains being responsible for tens of thousands of deaths per year. S. aureus sortase A inhibitors are designed to interfere with virulence determinants. We have identified disulfanylbenzamides as a new class of potent inhibitors against sortase A that act by covalent modification of the active-site cysteine. A broad series of derivatives were synthesized to derive structure-activity relationships (SAR). In vitro and in silico methods allowed the experimentally observed binding affinities and selectivities to be rationalized. The most active compounds were found to have single-digit micromolar Ki values and caused up to a 66 % reduction of S. aureus fibrinogen attachment at an effective inhibitor concentration of 10 μM. This new molecule class exhibited minimal cytotoxicity, low bacterial growth inhibition and impaired sortase-mediated adherence of S. aureus cells.en_GB
dc.language.isoengde
dc.rightsCC BY-NC-ND*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.ddc570 Biowissenschaftende_DE
dc.subject.ddc570 Life sciencesen_GB
dc.titleAsymmetric disulfanylbenzamides as irreversible and selective inhibitors of Staphylococcus aureus sortase Aen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-6261-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 09 Chemie, Pharmazie u. Geowissensch.de
jgu.organisation.number7950-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleChemMedChemde
jgu.journal.volume15de
jgu.journal.issue10de
jgu.pages.start839de
jgu.pages.end850de
jgu.publisher.year2020-
jgu.publisher.nameWiley-VCHde
jgu.publisher.placeWeinheim u.a.de
jgu.publisher.urihttps://doi.org/10.1002/cmdc.201900687de
jgu.publisher.issn1860-7187de
jgu.organisation.placeMainz-
jgu.subject.ddccode570de
jgu.publisher.doi10.1002/cmdc.201900687
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
barthels_fabian-asymmetric_dis-20210805114859449.pdf4.18 MBAdobe PDFView/Open